HSE have published their latest bulletins:
Classification Labelling and Packaging (CLP)
- ECHA public consultation: call for comments Deadline: 12 January 2024
The Great Britain mandatory classification and labelling (GB MCL) process includes the consideration of information gathered from public consultations, conducted by HSE or international bodies such as the European Chemicals Agency (ECHA). ECHA has announced a public consultation on the following proposal for harmonised classification and labelling (CLH):
- Exo-(+/-)-1-methyl-4-(1-methylethyl)-2-[(2-methylphenyl)methoxy]-7-oxabicyclo[2.2.1]heptane (EC: 402-410-9; CAS: 87818-31-3). Pesticidal active substance. All hazard classes open for commenting.
View the consultation on the ECHA website
UK-based businesses with an interest in the proposal are strongly encouraged to share any relevant information. Scientific and technical information should be submitted directly to ECHA using their commenting webform by 12 January 2024. Comments will be published on ECHA’s website.
If your business is affected by the GB CLP Regulation, please also consider if you are likely to be affected by the classification and labelling proposal and let us know at an early stage if you anticipate any significant impacts or benefits. Information on wider policy and impact consideration can be submitted to HSE at: GBCLP.GBMCL@hse.gov.uk.
Under the GB CLP Regulation, HSE will consider all published opinions of the Committee of Risk Assessment of ECHA (RAC) before publishing its own Agency Technical Reports and Agency Opinions, so any information you provide will be important in any final GB MCL decision. More information on the new GB MCL system is available on the HSE website
- Publication of GB MCL Agency Opinions
A GB MCL Agency Opinion formally proposes the GB mandatory classification and labelling for chemical substances, based on the scientific and technical assessment of the scientific data in line with the GB CLP Regulation, together with an assessment of the policy and socio-economic impacts on the UK
It sets out whether there is adequate scientific evidence to support a new or revised GB MCL of a substance and what the potential impact of the proposed GB MCL may be.
The next batch of 6 GB MCL Agency Opinions are now available for download in the GB MCL publication table (.xlsx).
These GB MCL Agency Opinions relate to substances for which HSE (as the GB CLP Agency) published an Agency Technical Report under Article 37 of the GB CLP Regulation in November 2022. At the time of publication, the classification and labelling proposed in this Agency Opinion has not been agreed and/or adopted in GB. For information on the next steps in the process, please see our webpage on the GB MCL system.
We expect to publish our next batch of Agency Opinions in December 2023. CLP ebulletin alerts will be issued when Agency Opinions are published on the HSE website. If you have any questions or feedback on the GB MCL Agency Opinions, please contact us at: GBCLP.GBMCL@hse.gov.uk. Journalists should contact HSE’s press office for further information.
Biocides
- EU active substance approval dates: Apply for product authorisation by the deadlines to keep your products on the NI market
The following EU BPR active substance approval dates are coming up:
- Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents (CAS 89997-63-7 EC 289-699-3) in product type 19 (1 February 2024)
- Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical CO2 (CAS 89997-63-7 EC 289-699-3) in product type 19 (1 February 2024)
- N,N-Didecyl-N,N-dimethylammonium chloride (Didecyldimethylammonium chloride) (DDAC) (CAS 7173-51-5 EC 230-525-2) in product types 01 and 02 (1 February 2024
If you supply biocidal products containing these active substances in the relevant product types, don’t forget to apply for EU BPR product authorisation by the dates above to keep them on the NI market.
- Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents (CAS 89997-63-7 EC 289-699-3) in product type 19 (1 February 2024)
-
EU active substance renewal submission deadlines
Apply for active substance renewal by the deadlines to keep products on the NI market
Under the EU BPR, active substance approvals will expire unless a renewal application is submitted to ECHA at least 550 days before their expiry date.
The 550-day deadlines are coming up for the following active substance/product type combinations under EU BPR. This affects NI:- 3-phenoxybenzyl(1R,3R)-2,2-dimethyl- 3-(2-methylprop-1-enyl)cyclopropanecarboxylate (1R-trans-Phenothrin) (CAS 26046-85-5 EC 247-431-2) in product type 18 (28 February 2024)
- bis(N-cyclohexyl-diazenium-dioxy)-copper (Cu-HDO) (CAS 312600-89-8 EC 239-703-4) in product type 08 (28 February 2024)
- Iodine (CAS 7553-56-2 EC 231-442-4) in product types 01, 03, 04 and 22 (28 February 2024)
- Isopropyl-(2E,4E,7S)-11-methoxy-3,7,11-trimethyl-2,4-dodeca-dienoate (S-methoprene) (CAS 65733-16-6 EC 613-834-0 ) in product type 18 (28 February 2024)
- n-Decanoic acid (Decanoic acid) (CAS 334-48-5 EC 206-376-4) in product types 04,18 and 19 (28 February 2024)
- n-Octanoic acid (Octanoic acid) (CAS 124-07-2 EC 204-677-5) in product types 04 and 18
(28 February 2024) - Polyvinylpyrrolidone iodine (CAS 25655-41-8 EC 607-771-8) in product types 01, 03, 04, 22 (28 February 2024)
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) (CAS 60207-90-1 EC 262-104-4) in product type 07 (29 May 2025)
- 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 13 (29 May 2025)
- 5-chloro-2-(4-chlorphenoxy)phenol (DCPP) (CAS 3380-30-1 EC 429-290-0) in product types 01, 02 and 04 (29 May 2025)
- Potassium (E,E)-hexa-2,4-dienoate (Potassium sorbate) (CAS 24634-61-5 EC 246-376-1) in product type 08 (29 May 2025)
Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.
Check the EU Article 95 List to see who the original supporters were.
If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know. If a renewal application is not submitted for the above active substance/product type combinations under EU BPR, the approvals will expire. This means the active substances can no longer be used in biocidal products or treated articles of the relevant product types in NI.
- 3-phenoxybenzyl(1R,3R)-2,2-dimethyl- 3-(2-methylprop-1-enyl)cyclopropanecarboxylate (1R-trans-Phenothrin) (CAS 26046-85-5 EC 247-431-2) in product type 18 (28 February 2024)
